Human Physiology

, Volume 35, Issue 4, pp 491–501

ω-3 polyunsaturated fatty acids and the cardiovascular system

  • S. A. Kryzhanovskii
  • M. B. Vititnova


ω-3 polyunsaturated fatty acids (PUFAs) (alpha-linolenic, eicosapentaenoic, and decosahexaenoic acids) are classified with essential fatty acids and are structural components of the phospholipid bilayer of cell membranes. ω-3 PUFAs incorporated into the phospholipid domain of cell membranes are metabolized to prostaglandins and thromboxanes (PGI3, PGE3, TxA, etc.), which significantly differ in biological activity from those formed in the arachidonic acid cascade (PGI2, PGE2, TxA2, etc.) and to which the antiaggregatory, antiatherogenic, and vasodilating effects of ω-3 PUFAs can largely be attributed. In addition, ω-3 PUFAs incorporated into cardiomyocyte cell membranes considerably modify the functional activity of transmembrane voltage-gated ion channels by causing a dose-dependent inhibition of the outward transmembrane sodium current, slowing down the work of transmembrane voltage-gated slow L-type calcium channels, and partially blocking the efflux of potassium ions from cardiomyocytes, thus showing the properties of class I, III, and IV antiarrhythmic drugs according to the Vaughnan Williams classification. Several clinical trials have supported experimental data that ω-3 PUFAs have membrane-stabilizing (antiarrhythmogenic) effects. For example, in the GISSI-Prevenzione trial, a large-scale, randomized, placebo-controlled study conducted in more than 9.5 thousand patients with left ventricular systolic dysfunction after myocardial infarction, ω-3 PUFA regular consumption significantly reduced the risk of sudden cardiac death by more than 50% in these patients. In our review, the mechanisms underlying the membrane-stabilizing, antiaggregatory, antiatherogenic, and vasodilating effects of ω-3 PUFAs and the clinical effectiveness of ω-3 PUFAs have been analyzed in terms of evidencebased pharmacology.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kromann, N. and Green, A., Epidemiological Studies in the Upernavik District, Greenland. Incidence of Some Chronic Disease 1950–1974, Acta Med. Scand., 1980, vol. 208, no. 5, p. 401.PubMedGoogle Scholar
  2. 2.
    Bang, H.O., Dyeberg, J., and Nielsen, A., Plasma Lipid and Lipoprotein Pattern in Greenlandic West-Coast Eskimos, Lancet, 1971, vol. 1, p. 143.Google Scholar
  3. 3.
    Njelekela, M., Ikeda, K., Mtabaji, J., and Yamori, Y. Dietary Habits, Plasma Polyunsaturated Fatty Acids, and Selected Coronary Disease Risk Factors in Tanzania, East. Afr. Med. J., 2005, vol. 82, no. 11, p. 572.PubMedGoogle Scholar
  4. 4.
    Bulliyya, G., Reddy, K.K., Reddy, G.P., et al., Lipid Profiles Fish-Consuming Coastal and Non-Fish-Consuming Inland Populations, Eur. Clin. Nutr., 1990, vol. 44, no. 6, p. 481.Google Scholar
  5. 5.
    Zhou, B.F., Stamler, J., Dennis, B., et al., Nutrient Intakes of Middle-Aged Men and Women in China, Japan, United Kingdom, and United States in the Late 1990s: the INTERMAP Study, J. Hum. Hypertens., 2003, vol. 17, no. 9, p. 623.PubMedCrossRefGoogle Scholar
  6. 6.
    Ueshima, H., Okyama, A., Saitoh, S., et al., Differences in Cardiovascular Disease Risk Factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID Study, J. Hum. Hypertens., 2003, vol. 17, no. 9, p. 631.PubMedCrossRefGoogle Scholar
  7. 7.
    Okuda, N., Ueshima, H., Okayama, A., et al., Relation of Long Chain N-3 Polyunsaturated Fatty Acid Intake to Serum High Density Lipoprotein Cholesterol along Japanese Men in Japan and Japanese-American Men in the INTERLIPID Study, Atherosclerosis, 2005, vol. 178, no. 2, p. 371.PubMedCrossRefGoogle Scholar
  8. 8.
    Hirai, A., Terano, T., Tamura, Y., and Yoshida, S., Eicosapentaenoic Acid and Adult Disease in Japan: Epidemiological and Clinical Aspects, J. Intern. Med. Suppl., 1989, vol. 731, p. 69.PubMedGoogle Scholar
  9. 9.
    Rodriguez, B.L., Sharp, D.S., Abbott, R.D., et al., Fish Intake May Limit the Increase in Risk of Coronary Heart Disease Morbidity and Mortality among Heavy Smokers. The Honolulu Heart Program, Circulation, 1996, vol. 94, no. 5, p. 952.PubMedGoogle Scholar
  10. 10.
    Kromhout, D., Bosschieter, E.B., and de Lezenne Coulander, C., The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease, N. Engl. J. Med., 1985, vol. 312, no. 19, p. 1205.PubMedGoogle Scholar
  11. 11.
    Hallgren, C.G., Hallmans, G., Jansson, J.H., et al. Markers of High Fish Intake Are Associated with Decreased Risk of a First Myocardial Infarction, Br. J. Nutr., 2001, vol. 86, no. 3, p. 397.PubMedCrossRefGoogle Scholar
  12. 12.
    Barringer, T.A., Mediterranean Diets and Cardiovascular Disease, Curr. Atheroscler. Rep., 2001, vol. 3, no. 6, p. 437.PubMedCrossRefGoogle Scholar
  13. 13.
    Mangiapane, E.H., Diet, Lipoproteins, and Coronary Heart Disease, in A Biochemic Respective, Mangiapane, E.H. and Salter, A.M., Eds., Nottingham, 1999, p. 180.Google Scholar
  14. 14.
    Wada, M., Delong, C.J., Hong, Y.H., et al., Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-Derived versus Eicosapentaenoic Acid-Derived Substrates and Products, J. Biol. Chem., 2007, vol. 282, no. 31, p. 22254.PubMedCrossRefGoogle Scholar
  15. 15.
    Li, B., Birdwell, Ch., and Whelan, J., Antithetic Relationship of Dietary Arachidonic Acid and Eicosapentaenoic Acid on Eicosanoid production in vivo, J. Lipid Res., 1994, vol. 35, p. 1869.PubMedGoogle Scholar
  16. 16.
    Kang, J.X. and Leaf, A., Evidence that Free Polyunsaturated Fatty Acids Modify Na+ Channels by Directly Binding to the Channel Proteins, Proc. Natl. Acad. Sci. USA, 1996, vol. 93, p. 3542.PubMedCrossRefGoogle Scholar
  17. 17.
    Xiao, Y.F., Gomes, A.M., Morgan, J.P., et al., Suppression of Voltage-Gated L-Type Ca++ Currents by Polyunsaturated Fatty Acids in Adult and Neonatal Rat Ventricular Myocytes, Proc. Natl. Acad. Sci. USA, 1997, vol. 94, p. 4182.PubMedCrossRefGoogle Scholar
  18. 18.
    Xiao, Y.F., Kang, J.X., Morgan, J.P., and Leaf, A., Blocking Effects of Polyunsaturated Fatty Acids on Na+ Channels of Neonatal Rat Ventricular Myocytes, Proc. Natl. Acad. Sci. USA, 1995, vol. 92, no. 24, p. 11000.PubMedCrossRefGoogle Scholar
  19. 19.
    O’Neill, S.C., Perez, M.R., Hammond, K.E., et al., Direct and Indirect Modulation of Rat Cardiac Sarcoplasmic Reticulum Function by N-3 Polyunsaturated Fatty Acids, J. Physiol., 2002, vol. 538,part 1, p. 179.PubMedCrossRefGoogle Scholar
  20. 20.
    Guizy, M., Arias, C., David, M., et al., ω-3 and ω-6 Polyunsaturated Fatty Acids Block HERG Channels, Am. J. Physiol. Cell Physiol., 2005, vol. 289, p. C1251.PubMedCrossRefGoogle Scholar
  21. 21.
    Honoré, E., Barhanin, J., Attali, B, et al., External Blockade of the Major Cardiac Delayed-Rectifier K+ Channel (Kv1,5) by Polyunsaturated Fatty Acids, Proc. Natl. Acad. Sci. USA, 1994, vol. 91, p. 1937.PubMedCrossRefGoogle Scholar
  22. 22.
    Xiao, Y.-F., Wright, S.N., Wang, G.K., et al., Fatty Acids Suppress Voltage-Gated Na+ Currents in HEK293t Cells Transfected with the α-Subunit of the Human Cardiac Na+ Channel, Proc. Natl. Acad. Sci. USA, 1998, vol. 95, p. 2680.PubMedCrossRefGoogle Scholar
  23. 23.
    Vaughan Williams E.M., Classification of Antiarrhythmic Drugs, in Symposium on Cardiac Arrhythmias, Sandfte E. et al., Eds., Astra, 1970, p. 449.Google Scholar
  24. 24.
    Leaf, A., Kang, J.X., Xiao, Y.-F., et al., Clinical Prevention of Sudden Cardiac Death by N-3 Polyunsaturated Fatty Acids and Mechanism of prevention of Arrhythmias by N-3 Fish Oils, Circulation, 2003, vol. 107, p. 2646.PubMedCrossRefGoogle Scholar
  25. 25.
    Broughton, K.Sh. and Wadw, J.W., Total Fat and (N-3):(N-6) Fat Rations Influence Eicosanoid Production in Mice, J. Nutr., 2002, vol. 132, p. 88.PubMedGoogle Scholar
  26. 26.
    Fischer, S. and Weber, P.C., Thromboxane A3 (TXA3) Is Formed in Human Platelets after Dietary Eicosapentaenoic Acid (C20:5 ω 3), Biochem. Biophys. Res. Commun., 1983, vol. 116, no. 3, p. 1091.PubMedCrossRefGoogle Scholar
  27. 27.
    Fisher, S. and Weber, P.C., Thromboxane A3 (TXA3) and Prostaglandin (PG)3 Are Formed in Man after Dietary Eicosapentaenoic Acid: Identification and Quantification by Capillary Gas Chromatography-Electron Impact Mass Spectrometry, Biomed. Mass Spectrom., 1985, vol. 12, no. 39, p. 470.CrossRefGoogle Scholar
  28. 28.
    Kinsella, J.E., Lokesh, B., and Stone, R.A., Dietary N-3 Polyunsaturated Fatty Acids and Amelioration of Cardiovascular Disease: Possible mechanisms, Am. J. Clin. Nutr., 1990, vol. 52, no. 1, p. 1.PubMedGoogle Scholar
  29. 29.
    Takahata, K. and Yamanaka, M., PG13 Production from Eicosapentaenoic Acid in 3T3 Fibroblast Cells and Cultured Bovine Pulmonary Artery Endothelial Cells, Thromb. Res., 1987, vol. 45, no. 5, p. 581.PubMedCrossRefGoogle Scholar
  30. 30.
    Galyavich, A.S. and Salakhova, L.P., A Disorder of Fatty Acid Metabolism during Atherosclerosis and Possibilities of Its Correction, Kardiol., 2006, no. 12, p. 36.Google Scholar
  31. 31.
    Connor, W.E., DeFrancesco, C.A., and Connor, S.L., N-3 Fatty Acids from Fish Oil. effects on Plasma Lipoproteins and Hypertriglyceridic Patients, Ann. N.Y. Acad. Sci., 1993, vol. 683, p. 16.PubMedCrossRefGoogle Scholar
  32. 32.
    Norum, K., Dietary Fat and Blood Lipids, Nutr. Rev., 1992, vol. 50, no. 4, p. 30.PubMedCrossRefGoogle Scholar
  33. 33.
    Harris, W.S., Dietary Fish Oil and Blood Lipids, Cur. Opin. Lipidol., 1996, vol. 7, p. 3.CrossRefGoogle Scholar
  34. 34.
    Zhu, B.Q. and Parmley, W.W., Modification of Experimental and Clinical Atherosclerosis by Dietary Fish Oil, Am. Heart J., 1990, vol. 119, no. 1, p. 168.PubMedCrossRefGoogle Scholar
  35. 35.
    Coniglio, J.G., How Does Fish Oil Lower Plasma Triglycerides, Nutr. Rev., 1992, vol. 50, no. 7, p. 195.PubMedGoogle Scholar
  36. 36.
    Matsuo, N., Yamada, K., Mori, M., et al., Inhibition by Dietary Tea Polyphenols of Chemical Mediator Release from Rat Peritoneal Exudate Cells, Biosci. Biotechnol. Biochem., 2000, vol. 64, no. 7, p. 1437.PubMedCrossRefGoogle Scholar
  37. 37.
    Hall, J.A., Van Saun, R.J., and Wander, R.C., Dietary (N-3) Fatty Acids from Menhaden Fish Oil after Plasma Fatty Acids and Leukotriene B Synthesis in Healthy Horses, J. Vet. Intern. Med., 2004, vol. 18, no. 6, p. 871.PubMedCrossRefGoogle Scholar
  38. 38.
    Whelan, J., Li, B., and Birdwell, C., Dietary Arachidonic Acid Increases Eicosanoid Production in the Presence of Equal Amounts of Dietary Eicosapentaenoic Acid, Adv. Exp. Med. Biol., 1997, vol. 400B, p. 897.PubMedGoogle Scholar
  39. 39.
    Niu, K., Hozawa, A., Kuriyama, S., et al., Dietary Long-Chain N-3 Fatty Acids of Marine Origin and Serum C-Reactive protein Concentrations Are Associated in a Population with a Diet Rich in Marine Products, Am. J. Clin. Nutr., 2006, vol. 84, no. 1, p. 223.PubMedGoogle Scholar
  40. 40.
    Zhao, G., Etherton, T.D., Martin, K.R., et al., Dietary Alpha-Linolenic Acid Reduces Inflammatory and Lipid cardiovascular Risk Factors in Hypercholesterolemic Men and Women, J. Nutr., 2004, vol. 134, no. 11, p. 2991.PubMedGoogle Scholar
  41. 41.
    Leaf, A. and Weber, P.C., Cardiovascular Effects of N-3 Fatty Acids, N. Engl. J. Med., 1988, vol. 318, no. 9, p. 549.PubMedGoogle Scholar
  42. 42.
    Shimokawa, H., Aarhus, L.L., and Vanhoutte, P.M., Dietary ω 3 Polyunsaturated Fatty Acids Augment Endothelium-Dependent Relaxation by Bradykinin in Coronary Microvessels of the Pig, Br. J. Pharmacol., 1988, vol. 95, no. 34, p. 1191.PubMedGoogle Scholar
  43. 43.
    Shimokawa, H. and Vanhoutte, P.M., Dietary omega 3 Polyunsaturated Fatty Acids and Endothelium-Dependent Relaxations in Porcine Coronary Arteries, Am. J. Physiol., 1989, vol. 256, no. 4, part 2, p. H968.PubMedGoogle Scholar
  44. 44.
    Drevon, C.A., N-6 and N-3 Fatty Acids-How Much and Which Balance, Scand. J. Nutr., 1990, vol. 34, p. 56.Google Scholar
  45. 45.
    Iso, H., Kobayashi, M., Ishihara, J., et al., Intake of Fish and N-3 Fatty Acids and Risk of Coronary Heart Disease among Japanese. The Japan Public Health Center-based (JPHC) Study Cohort I, Circulation, 2006, vol. 113, p. 195.PubMedCrossRefGoogle Scholar
  46. 46.
    Singh, R.B., Niaz, M.A., Sharma, J.P., et al., Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: the Indian Experiment of Infarct Survival-4, Cardiovasc. Drugs Ther., 1997, vol. 11, no. 3, p. 485.PubMedCrossRefGoogle Scholar
  47. 47.
    Oomen, C.M., Feskens, E.J.M., Räsänen, L., et al., Fish Consumption and Coronary Heart Disease Mortality in Finland, Italy, and the Netherlands, Am. J. Epidemiol., 2000, vol. 151, p. 999.PubMedGoogle Scholar
  48. 48.
    Mozaffarian, D., Aschero, A., Hu, F.B., et al., Interplay between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men, Circulation, 2005, vol. 111, p. 157.PubMedCrossRefGoogle Scholar
  49. 49.
    Järvinen, R., Knekt, P., Rissanen, H., and Reunanen, A., Intake of Fish and Long-Chain N-3 Fatty Acids and the Risk of Coronary Heart Mortality in Men and Women, Br. J. Nutr., 2006, vol. 95, no. 4, p. 824.PubMedCrossRefGoogle Scholar
  50. 50.
    König, A., Bouzan, C., Cohen, J.T., et al., A Quantitative Analysis of Fish Consumption and Coronary Heart Disease Mortality, Am. J. Prev. Med., 2005, vol. 29, no. 4, p. 335.PubMedCrossRefGoogle Scholar
  51. 51.
    Harper, Ch.R. and Jacobson, T.A., The Role of ω-3 Fatty Acids in the Prevention of Coronary Heart Disease, Arch. Intern. Med., 2001, vol. 161, p. 2185.PubMedCrossRefGoogle Scholar
  52. 52.
    De Logeril, M., Salen, P., Defaye, P., et al., Dietary Prevention of Sudden Cardiac Death, Eur. Heart J., 2002, vol. 23, p. 277.CrossRefGoogle Scholar
  53. 53.
    Marckmann, P. and Grønbaek, M., Fish Consumption and Coronary Heart Disease Mortality. A Systematic Review of Prospective Cohort Studies, Eur. J. Clin. Nutr., 1999, vol. 53, no. 8, p. 585.PubMedCrossRefGoogle Scholar
  54. 54.
    Lee, K.W. and Lip, G.Y.H., The Role of ω-3 Fatty Acids in the Secondary Prevention of Cardiovascular Disease, Q. J. Med., 2003, vol. 96, p. 465.Google Scholar
  55. 55.
    He, K., Song, Y., Daviglus, M.L., et al., Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality. A Meta-Analysis of Cohort Studies, Circulation, 2004, vol. 109, p. 2705.PubMedCrossRefGoogle Scholar
  56. 56.
    Morris, M.C., Manson, J.E., Rosner, B., et al., Fish Consumption and Cardiovascular Disease in the Physician’s Health Study: A Prospective Study, Am. J. Epidemiol., 1995, vol. 142, no. 2, p. 166.PubMedGoogle Scholar
  57. 57.
    Lichtenstein, A.H., Appel, L.J., Brands, M., et al., Diet and Lifestyle Recommendations Revision 2006. A Scientific Statement from the American Heart Association Nutrition Committee, Circulation, 2006, vol. 114, p. 82.PubMedCrossRefGoogle Scholar
  58. 58.
    Kris-Etherton, P.M. and Innis, S., Position of the American Dietic Association and Dietitians of Canada: Dietary Fish Acids, J. Am. Diet Assoc., 2007, vol. 107, no. 9, p. 1599.PubMedGoogle Scholar
  59. 59.
    Dietary Supplementation with N-3 Polyunsaturated fatty Acids and Vitamin E after Myocardial Infarction: Results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico, Lancet, 1999, vol. 354, no. 9177, p. 447.Google Scholar
  60. 60.
    Burr, M.L., Fehily, A.M., Gilbert, J.F., et al., Effects of Changes in Fat, Fish, and Fibrate Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART), Lancet, 1989, vol. 2, no. 8666, p. 757.PubMedCrossRefGoogle Scholar
  61. 61.
    Marchioli, R., Barzi, F., Bomba, E., et al., On Behalf of the GISSI-Prevenzione Investigators. Early Protection against Sudden Death by N-3 Polyunsaturated Fatty Acids after Myocardial Infarction, Circulation, 2002, vol. 105, p. 1897.PubMedCrossRefGoogle Scholar
  62. 62.
    Macchia, A., Levantesi, G., Franzosi, M.G., et al., Left Ventricular Systolic Dysfunction, Total Mortality, and Sudden Death in Patients with Myocardial Infarction treated with N-3 Polyunsaturated Fatty Acids, Eur. J. Heart Fail., 2005, vol. 7, no. 5, p. 904.PubMedCrossRefGoogle Scholar
  63. 63.
    Albert, Ch., Campos, H., Stampfer, M., et al., Blood Levels of Long-Chain N-3 Fatty Acids and the Risk of Sudden Death, N. Engl. J. Med., 2002, vol. 346, p. 1113.PubMedCrossRefGoogle Scholar
  64. 64.
    Siscovick, D.S., Lemaitre, R.N., and Mozaffarian, D., The Fish Story. A Diet-Heart Hypothesis with Clinical Implications: N-3 Polyunsaturated Fatty Acids, Myocardial Vulnerability, and Sudden Death, Circulation, 2003, vol. 107, no. 21, p. 2632.PubMedCrossRefGoogle Scholar
  65. 65.
    Albert, Ch.M., Hennekens, Ch.H., O’Donnell, Ch.J., et al., Fish Consumption and Risk of Sudden Cardiac Death, JAMA, 1998, vol. 279, no. 1, p. 23.PubMedCrossRefGoogle Scholar
  66. 66.
    Geelen, A., Brouwer, I.A., Schouten, E.G., et al., Effects of N-3 Fatty Acids from Fish on Premature Ventricular Complexes and Heart Rate in Humans, Am. J. Clin. Nutr., 2005, vol. 81, no. 2, p. 416.PubMedGoogle Scholar
  67. 67.
    Singer, P. and Writh, M., Can N-3 PUFA Reduce Cardiac Arrhythmias? Results of a Clinical Trial, Prostagland. Leukot. Essent. Fatty Acids, 2004, vol. 71, no. 3, p. 153.CrossRefGoogle Scholar
  68. 68.
    Mozaffarian, D., Psaty, B., Rimm, E.B., et al., Fish Intake and Risk of Incident Atrial Fibrillation, Circulation, 2004, vol. 110, p. 368.PubMedCrossRefGoogle Scholar
  69. 69.
    McLennan, P.L., Myocardial Membranes Fatty Acids and the Antiarrhythmic Actions of Dietary Fish Oil in Animal Models, Lipids, 2001, vol. 36,suppl., p. S111.PubMedCrossRefGoogle Scholar
  70. 70.
    Brilman, G.E., Kang, J.X., and Leaf, A., Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs, Circulation, 1999, vol. 99, p. 452.Google Scholar
  71. 71.
    Brouwer, I.A., Zock, P.L., Camm, A.J., et al., Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients with Implantable Cardioverter Defibrillators: the Study on ω-3 Fatty Acids and Ventricular Arrhythmia (SOFA) Randomized Trial, JAMA, 2006, vol. 295, no. 22, p. 2613.PubMedCrossRefGoogle Scholar
  72. 72.
    Christensen, J.H., Gustenhoff, P., Korup, E., et al., Effect of Fish Oil on Heart Rate Variability in Survivors of Myocardial Infarction: A Double-Blind Randomized Controlled Trial, Br. Med. J., 1996, vol. 312, p. 677.Google Scholar
  73. 73.
    Mozaffarian, D., Greelen, A., Brouwer, I.A., et al., Effect of Fish Oil on Heart Rate in Humans. A Meta-Analysis of Randomized controlled Trials, Circulation, 2005, vol. 112, p. 1945.PubMedCrossRefGoogle Scholar
  74. 74.
    O’Keefe, J.H., Abuissa, H., Sastre, A., et al., Effects of ω-3 Fatty Acids on Resting Heart Rate, Heart Rate Recovery after Exercise, and Heart Rate Variability in Men with Healed Myocardial Infarctions and Depressed Ejection Fractions, Am. J. Cardiol., 2006, vol. 97, no. 8, p. 1127.PubMedCrossRefGoogle Scholar
  75. 75.
    Christensen, J.H. and Schmidt, E.B., N-3 Fatty Acids and the Risk of Sudden cardiac Death, Lipids, 2001, vol. 36,suppl., p. S115.PubMedCrossRefGoogle Scholar
  76. 76.
    Christensen, J.H., Christensen, M.S., Dyerberg, J., and Schmidt, E.B., Heart Rate Variability and Fatty Acid Content of Blood Cell Membranes: A Dose-Response Study with N-3 Fatty Acids, Am. J. Clin. Nutr., 1999, vol. 70, p. 331.PubMedGoogle Scholar
  77. 77.
    Christensen, J.H., Gustenhoff, P., Korup, E., et al., N-3 Polyunsaturated Fatty Acids, Heart Rate Variability, and Ventricular Arrhythmias in Post-AMI-Patients. A Clinical Controlled Trial, Ugeskr. Laeger., 1997, vol. 159, no. 37, p. 5525.PubMedGoogle Scholar
  78. 78.
    Task Force on Sudden Cardiac Death of European Society of Cardiology, Eur. Heart J., 2001, vol. 22, p. 1374.Google Scholar
  79. 79.
    ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death), J. Am. Coll. Cardiol., 2006, vol. 48, p. 247.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2009

Authors and Affiliations

  • S. A. Kryzhanovskii
    • 1
  • M. B. Vititnova
    • 1
  1. 1.V.V. Zakusov Institute of PharmacologyRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations